本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
KUALA LUMPUR, Malaysia, March 20, 2023 /PRNewswire/ -- In the latest Times Higher Education (THE) World University Rankings 2023, Sunway University is the No. 1 non-government linked university (GLU) private university in Malaysia and ranked as one of Malaysia's Top 10 universities. Sunway University is now ranked 801-1000, out of 1,799 universities across 104 countries and regions. THE World University Rankings is the largest and most diverse university rankings. Professor Sibrandes Poppema, President of Sunway University shared, "We are very pleased to have entered the Times Higher Education World University Rankings for meeting the eligibility criteria to receive a rank in the league table." The table is calibrated carefully with 13 performance indicators that measure an institution's performance across four areas: teaching, research, knowledge transfer and international outlook. The data compile produces these rankings that are trusted by governments and universities, which are a vital source for students when they are making decisions about where to study. In addition, Sunway University is also the top-ranked private university in Malaysia for THE Impact Rankings 2022, ranked Top 301+ out of 1,406 international institutions. THE Impact Rankings recognise universities worldwide for their social and economic impact based on the United Nations' Sustainable Development Goals (SDGs). Sunway University is highly-ranked in the Top 200 in SDG 6 – Clean Water and Sanitation, SDG 8 – Decent Work and Economic Growth and SDG 17 – Partnership for the Goals; Top 300 in SDG 7 – Affordable and Clean Energy and a high score in SDG 11 – Sustainable Cities and Communities. As part of the effort to prepare students for their future careers, Sunway University put great emphasis on developing graduates who are highly sought-after by employers and are equipped for all of life's challenges and opportunities. In the International Student Barometer 2021 survey, Sunway University ranked number one in 'Career Support', with a 92.3% satisfaction rate compared to the average of 77.6% globally. According to the Sunway Career Services 2020/2021 report in Malaysia, the Top 10 Companies hiring Sunway graduates included Accenture, AIA, Ernst & Young, Great Eastern Life Assurance, Maybank, Prudential Assurance, Public Bank, PricewaterhouseCoopers (PwC), Shopee and Sunway Group and subsidiaries. Sunway University also received the number one award in Graduate Employability among all universities in Malaysia by Talentbank Group through the National Graduate Employability Index (GE Index). The survey gauges the employability rate of graduates from universities all across Malaysia, highlighting Malaysian universities that have produced the most highly sought-after graduates. "From here on Sunway University will continue to go upward as our numbers of articles and citations have rapidly gone up in the past two years. The reputation of our education and research is growing, especially because of the global number one position in the International Student Barometer for Career Support and the Malaysian number one position in Graduate Employability."
Transaction generates net proceeds to Mainstream of approximately USD 90 million, subject to certain closing adjustments Lekela is the African continent's largest pure-play renewable energy Independent Power Producer (`IPP') with over 1 GW of fully operational wind assets The planned exit reflects the successful culmination of Mainstream and Actis' partnership strategy for Lekela FORNEBU, Norway, March 20, 2023 /PRNewswire/ -- Reference is made to the stock exchange announcement by Aker Horizons ASA dated 18 July 2022 regarding Mainstream Renewable Power ("Mainstream"), the global wind and solar company majority-owned by Aker Horizons, and Actis', a leading global investor in sustainable infrastructure, agreement to sell the Lekela Power platform. Mainstream and Actis today announced the completion of the sale of 100 percent of the Lekela platform to Infinity Power, a joint venture between Egypt's Infinity and UAE's Masdar. The transaction generates net proceeds to Mainstream of approximately USD 90 million, subject to certain closing adjustments, with the transaction valued at an enterprise value of approximately USD 1.5 billion. Lekela was established in 2015 in a joint venture between Actis (60 percent), and a Mainstream-led consortium called Mainstream Renewable Power Africa Holdings ('MRPAH') (40 percent), to deliver clean, reliable energy across Africa. Lekela has since become Africa's largest pure-play renewable energy IPP, with over 1 GW of fully-operational wind assets, including five operational wind farms in South Africa (624 MW), one operational wind farm in Egypt (252 MW), one operational wind farm in Senegal (159 MW) as well as development opportunities in Ghana, Senegal and Egypt. The exit reflects the successful culmination of Actis and Mainstream's partnership strategy for Lekela, following a comprehensive value creation approach. With the support of Actis and Mainstream's dedicated sustainability professionals, Lekela has implemented the highest international standards in health, safety and environmental protection. Lekela has also developed a deep commitment to local development and continues to operate a community investment programme that finances entrepreneurship, educational and environmental protection initiatives. Throughout the development, construction and operations journey, Actis and Mainstream have delivered on their robust sustainable development standards, guided by close engagement with local communities. "We are immensely proud of the role we have played in building and nurturing what is today Africa's largest pure-play renewable energy IPP and I am confident that Lekela will continue to make a major contribution to a just, and therefore sustainable, energy transition. Mainstream is deeply committed to our mission of leading the global transition to renewable energy and our 150-strong proudly South African team is focused on bringing our 11.5 GW pipeline of wind and solar projects in South Africa to fruition this decade and beyond," said Mary Quaney, Group Chief Executive of Mainstream Renewable Power. Citi and Clifford Chance advised Mainstream and Actis on the Lekela transaction. For further information, please contact: Emmet Curley, Communications, Mainstream Renewable PowerTel: +353 86 2411 690Emmet.curley@mainstreamrp.com Elizabeth Adams, FTI ConsultingTel: +44 7974 982331 Christian Yggeseth, Investor Relations, Aker HorizonsTel: +47 915 10 000,christian.yggeseth@akerhorizons.com About Mainstream Renewable Power Mainstream Renewable Power is a leading pure-play renewable energy company, with wind and solar assets across global markets, including in Latin America, Africa, and Asia-Pacific. Mainstream is one of the most successful developers of gigawatt-scale renewables platforms, across onshore wind, offshore wind, and solar power generation. It has successfully delivered 6.5 GW of wind and solar generation assets to financial close-ready and has a global pipeline of over 21.7 GW, with 1.5 GW in operation and under construction. www.mainstreamrp.com About Aker HorizonsAker Horizons develops green energy and green industry to accelerate the transition to Net Zero. The company is active in renewable energy, carbon capture and hydrogen and develops industrial scale decarbonization projects. As part of the Aker group, Aker Horizons applies industrial, technological and capital markets expertise with a planet-positive purpose to drive decarbonization globally. Aker Horizons is listed on the Oslo Stock Exchange and headquartered in Fornebu, Norway. Through its portfolio companies, Aker Horizons employs over 1,200 people across 18 countries and five continents.www.akerhorizons.com
ActivChallenge: A Brand New 7-day Home Based Fitness Challenge Catered To Every One Of All Fitness Levels SINGAPORE, March 20, 2023 /PRNewswire/ -- CardsPal is the official ticketing partner for Singapore's first personalized 7-day home fitness challenge, ActivChallenge, which is set to kick off on May 1st, 2023. Kelvin Goh, a former competitive runner and swimmer during his school days, conceived the idea of ActivChallenge. Today, as the founder of ActivEdge, a tech-focused fitness app based in Singapore, he has brought his vision to life with the use of AI and machine learning to create custom workout lists for users based on their health, fitness, and lifestyle habits. By joining forces with ActivEdge, CardsPal hopes to provide a unique fitness experience to their users while offering lifestyle experiences beyond their Cashback Calculator and Must-Buy Deals Marketplace. CardsPal recently partnered with Seedly for their Finance Festival 2023 and served as the exclusive ticketing partner for Singapore's first-ever hard dance music festival, Glowhard in November 2022, showcasing their commitment to exploring new and exciting avenues for their valued pals. With health and fitness being areas that everyone should improve, virtual challenges can be a convenient alternative to help kickstart a fitness journey. The ActivChallenge can also provide a sense of community and support, while also offering incentives for participants to push themselves further. By leveraging on AI and machine learning, these challenges are customized to suit users' fitness levels and goals. Co-founder and CEO of CardsPal, Saim Yeong Harng said: "With the upcoming ActivChallenge, we hope to empower our pals to take charge of their health and wealth as part of our greater journey to becoming your preferred digital lifestyle pal." Saim added: "Through this partnership, CardsPal aims to transform the way our pals approach fitness and well-being. CardsPal believes that this is just the beginning of a long and fruitful relationship between us and ActivEdge who share a common goal of helping people live their best lives." ActivChallenge is a virtual fitness challenge that runs for seven days, offering daily fitness tasks with the added motivation of cash and prizes, along with a sense of community and connection among participants. The challenge provides customized exercises tailored to each user's fitness level and preferences, making it accessible and convenient. Participants can claim over $100 in rewards as they complete workouts throughout the challenge, in addition to a share of the cash bonus of $3,000. Founder of ActivEdge, Kelvin Goh said: "The challenge was designed with everyone in mind, regardless of their fitness level. With the help of technology, even fitness beginners will have an equal opportunity to participate and potentially win. The two-fold goal of ActivChallenge is to make starting a fitness journey easy and affordable, and to turn exercise into a habit for long-term health benefits." Tickets for the ActivChallenge are now open for sale on CardsPal, sign up now to embark on the transformative fitness journey of a lifetime. About CardsPal CardsPal is a Singapore-based mobile app that aims to be the lifestyle app to add to your daily life. Enabling our pals to identify their best payment option to allow ease of purchases as they focus on living the life they deserve. CardsPal is backed by Standard Chartered Bank via its innovation arm, SC Ventures. Check out CardsPal by downloading the app on the App Store and Google Playstore. For latest information on deals and events, follow CardsPal on Facebook, Instagram, Telegram and LinkedIn. About ActivEdge ActivEdge is a technology-first fitness app, that dynamically personalizes a list of achievable workouts for each user to make regular exercises easy to start, and fun to repeat. Find out more about ActivEdge on www.activedge.sg and download the app on the App Store and Google Playstore. Follow ActivEdge on Facebook and Instagram for the latest updates. SC Ventures SC Ventures is a business unit that provides a platform and catalyst for Standard Chartered to promote innovation, invest in disruptive financial technology, and explore alternative business models. For more information, please visit scventures.io and follow SC Ventures on LinkedIn. Standard Chartered We are a leading international banking group, with a presence in 59 of the world's most dynamic markets and serving clients in a further 64. Our purpose is to drive commerce and prosperity through our unique diversity, and our heritage and values are expressed in our brand promise, here for good. Standard Chartered PLC is listed on the London and Hong Kong Stock Exchanges. For more stories and expert opinions please visit Insights at sc.com. Follow Standard Chartered on Twitter, LinkedIn, Instagram and Facebook. Media Contact:Gary GarciaGary.Garcia@cardspal.com
The Golden Ticket will help to boost the biotech startup's capabilities and to develop further the emerging biotech ecosystem in Southeast Asia SINGAPORE, March 20, 2023 /PRNewswire/ -- Leading global biotechnology company Amgen and NSG BioLabs, Singapore's largest and leading provider of biotechnology (biotech) co-working laboratories and offices, announced Albatroz Therapeutics as the winner of the first Amgen Golden Ticket in Singapore. Albatroz Therapeutics will be rewarded a one-year free residency in NSG Biolabs' fully-equipped, turnkey, and certified BSL-2 laboratory, as well as additional facility benefits and connections to Amgen's scientific and business leaders. The Amgen Golden Ticket winner was chosen by an internal team of Amgen scientific leaders at a virtual pitch event. In the final round of the competition, 5 finalists pitched their business plans before Amgen's internal scientific committee that evaluated the strength and novelty of the participants' scientific rationale, subject matter expertise and business plan viability. Albatroz Therapeutics was announced as the winner at an award ceremony held at the Amgen Singapore Manufacturing facility on 15 March, where Singapore Minister of State for Trade and Industry, Mr. Alvin Tan, was the guest of honour. In addition to accessing NSG BioLabs' capabilities, the award winner's access to a vast network of scientific and business leaders is a key proponent of the Golden Ticket prize – which Albatroz Therapeutics can now leverage to execute its scientific goals. "Amgen's exciting new partnership with NSG BioLabs at Biopolis is contributing to the evolution of Singapore's biotech ecosystem – aligning with our mission to discover, develop and deliver life-changing medicines to patients everywhere. We are excited about the universal cancer therapy and anti-arthritic platform being developed by Albatroz Therapeutics in Singapore, and we look forward to engaging with the team as they help to advance the leveraging of novel biotherapeutics to treat grievous illnesses plaguing our world today," said Alan Russell, Vice President, Biologics Therapeutic Discovery, Amgen. Launched in early 2022, the Golden Ticket sponsorship[1] was the first sponsorship announced by the NSG Tomorrow Program to accelerate the growth of innovative biotech startups and aid them in executing their vision. NSG Tomorrow seeks to provide crucial support, network access, and environment to empower ambitious biotech startups. With two more Amgen Golden Tickets being up for grabs over the next two years, Amgen and NSG BioLabs stand by their commitment to achieving a shared vision of helping biotech startups grow and facilitating Southeast Asia's transition into a regional biotech powerhouse. "Singapore is looking to generate a good pipeline of therapeutic assets that will contribute to the health of people in Singapore and around the world. To achieve this, the right infrastructure and resources are necessary to enable the growth of biotech startups here. Amgen and NSG BioLabs are key players that the Singapore Government has anchored in the ecosystem. We are happy to support this partnership, as it provides mentorship and support that can accelerate a startup's journey in this space," said Soh Leng Wan, Assistant CEO, Manufacturing and Engineering, Enterprise Singapore. Launched in 2019, NSG BioLabs has helped its resident startups achieve notable breakthroughs, achieving over S$100 million in funds raised, major partnerships, and new product launches since 2020. Albatroz Therapeutics now joins over 20 local and international resident companies with diverse expertise in transformative and life-changing technologies and applications ranging from genome editing to cancer immunotherapy, artificial intelligence, neurodegeneration drug discovery, precision medicine, synthetic biology and more. "The Amgen Golden Ticket is a transformative prize for biotech startups as it addresses the pressing concerns of a lack of resources, access, and support. Our dynamic winner, Albatroz Therapeutics, will join our diverse community of residents that already includes successful scientific innovators such as L'Oréal Research & Innovation and Oxford Nanopore Technologies, in addition to promising local startups like Engine Biosciences and ImmunoScape. With them having access to our state-of-the-art equipment and space, we look forward to witnessing future developments that Albatroz will lead," said Daphne Teo, CEO and Founder of NSG BioLabs. For more details about the NSG Tomorrow and Amgen Golden Ticket, visit nsgtomorrow.com About NSG BioLabs Founded with a focus on supporting early-stage biotech companies, NSG BioLabs offers state-of-the-art equipment, efficient operations, capital efficiency, the expertise of world-class teams and global networks to incubate and assist emerging life sciences companies. The conducive R&D environment contains fully-equipped, certified BSL-2 laboratory and office infrastructure across 22,000 sq ft in the prime location of Biopolis. With access to a global network and a shared set of skills and experience with its strategic partners, NSG BioLabs ensures that biotech startups can execute on their cutting-edge research and development ecosystem in Singapore, leading to the innovation of revolutionary technologies and products that translate into breakthrough biotech ventures and impact for patients. For more information, visit www.nsgbio.com About Amgen Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing, and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the Nasdaq-100 index. In 2021, Amgen was named one of the 25 World's Best Workplaces™ by Fortune and Great Place to Work™ and one of the 100 most sustainable companies in the world by Barron's. For more information, visit www.amgen.com About Albatroz Therapeutics Albatroz Therapeutics Pte. Ltd. is a Singapore-based biotechnology company developing first-in-class antibody therapeutics to treat solid tumours and arthritic disorders. The novel technology was developed by the founders' team at the Agency for Science, Technology and Research (A*STAR), Singapore. Founded in 2020, the company holds an exclusive licence for rights to the technology patent portfolio. The company's unique proprietary target is involved in extracellular matrix degradation, a process critical to tumour growth and metastasis as well as synovial membrane destruction in arthritis. For more information, please visit http://www.albatroztherapeutics.com [1] https://www.prnewswire.com/news-releases/amgen-and-nsg-biolabs-announce-golden-ticket-to-boost-singapores-biotech-ecosystem-301557722.html
SAN FRANCISCO, March 18, 2023 /PRNewswire/ -- CliCli is excited to announce that its innovative accessible game creation tool and global distribution platform, is now available for alpha testing. CliCli seeks to offer more choices to the industry by simplifying game development and offering ample opportunities for financial success to developers.   CliCli's all-in-one service streamlines the game development process by offering editing tools, distribution, customer support, payment processing, user acquisition, community management, and long-term monetization. Creators don't need any coding experience to get started - anyone can use CliCli's graphical user interface to design game logic, control events, conditions, and actions, and access a free-to-use resource library of thousands of editable assets including characters, buildings, and music. CliCli's flexible monetization modes include options like Free-to-Play, Pay-to-Play, subscriptions, and battle passes, giving creators flexibility in how they achieve financial success. At GDC 2023, CliCli will debut globally and share its approach to building a sustainable UGC ecosystem. Developers attending the event can visit booth S1332 to try out the innovative game platform, join CliCli's creator sharing sessions, and win special rewards by completing editor challenges. Several games created by the CliCli editor will also be exclusively revealed at the exhibition, including Game of Rollink. "We built CliCli to help creators and independent developers overcome the common obstacles encountered when pursuing their passion, including tools learning, audience targeting, game marketing, and earning a living from it. We aim to support every creator in our community and we're so excited to see how creators use our game creation tool to achieve their dreams." stated Kun Li, Head of Operation of CliCli. CliCli continuously supports talented creators through game jams, monthly recurring events, and partnership programs. Hundreds of UGC creators are already using CliCli to build demos, playtest game ideas, and share the fun with their friends. With CliCli, the possibilities for creators are vast. Join the community today and start developing your dream game! About CliCli Based in Singapore, CliCli comprises a team of 200+ passionate industry professionals aiming to build new game experiences with creators around the world. CliCli is invested in by NetEase Games, the online games division of NetEase, Inc. (NASDAQ: NTES and HKEX: 9999), while all design decisions are that of the CliCli team. Official Website FacebookDeveloper Discord TwitterPlayer Discord RedditGame of Rollink Itch.io
CHENGDU, China, March 17, 2023 /PRNewswire/ -- Senmiao Technology Limited ("Senmiao" or the "Company") (Nasdaq: AIHS), a financing and servicing company focused on the online ride-hailing industry in China as well as an operator of its own online ride-hailing platform, today announced the operating metrics for its proprietary online ride-hailing platform for the month of February 2023. In February 2023, Senmiao and its affiliates recorded over 0.7 million total completed orders, a 28.3% increase from approximately 0.6 million total orders completed in January 2023, as a result of ride-hailing activity returning to pre-holiday levels following the Lunar New Year in late January. Numbers reported since August 2021 include the number of completed orders from Meituan's ride-hailing platform ("the Meituan platform") utilizing Senmiao's network of cars and drivers for a set monthly fee. Numbers reported since April 2022 include the number of completed orders from several other ride-hailing platforms in Chengdu (Xiehua, Anma and other platforms), under the same cooperation model as Meituan. Since the launch of Senmiao's online ride-hailing platform in October 2020, over 21.6 million rides have been completed using its own platform. Approximately 5.4 million rides have been completed on the Meituan platform under Senmiao's partnership with Meituan since August 2021. Over 1.7 million rides have been completed on Xiehua, Anma and other platforms since April 2022. The number of drivers completing rides via all the platforms (known as Active Drivers) in February 2023 was 5,973, up approximately 23.7% from 4,830 in January 2023. The table below presents approximate unaudited operating metrics of Senmiao and its affiliates' online ride-hailing platform since the launch in October 2020. CompletedOrders underOriginalModel[1] (in 000s) CompletedOrders underNew Model[2] (in 000s) TotalCompletedOrders (in 000s) Total Fares Paidby Riders (in 000s USD$) ActiveDrivers Oct-Dec 2020 1,318 1,318 4,039 N/A Jan-Dec 2021 13,360 2,485 15,845 49,505 N/A Jan 2022 455 492 947 3,413 7,085 Feb 2022 344 371 715 2,651 6,008 Mar 2022 534 480 1,014 3,660 7,091 Apr 2022 502 369 871 3,009 6,095 May 2022 581 357 938 3,286 5,989 Jun 2022 602 319 921 3,290 5,862 Jul 2022 636 337 973 3,504 5,928 Aug 2022 617 400 1,017 3,583 6,778 Sep 2022 414 114 528 1,712 6,030 Oct 2022 600 306 906 2,794 7,574 Nov 2022 456 298 754 2,267 7,019 Dec 2022 390 267 657 1,973 6,682 Jan 2023 338 239 577 1,928 4,830 Feb 2023 460 276 736 2,328 5,973 Cumulative 21,607 7,110 28,717 92,942 N/A [1] Under the original model, orders come from partner platforms and are completed by Senmiao's own platform. A rider can search for taxi/ride-hailing services on Senmiao's partner platforms, which then provide the rider with options for online ride-sharing service providers, including Senmiao. If the rider selects Senmiao, the order will then be distributed to registered drivers on Senmiao's own platform for viewing and acceptance and then completed by Active Drivers. Senmiao earns commissions for each completed order based on a certain percentage of the value of the order. [2] Under the new model, orders go through partner platforms but do not utilize Senmiao's own platform. Online ride-hailing requests and orders will be completed on the partner platforms utilizing Senmiao and its affiliates' network of cars and drivers for a set monthly fee. Starting from April 2022, the number includes orders completed on the Xiehua, Anma and other platforms, in addition to those completed on the Meituan platform since August 2021. About Senmiao Technology Limited Headquartered in Chengdu, Sichuan Province, Senmiao provides automobile transaction and related services including sales of automobiles, facilitation and services for automobile purchases and financing, management, operating leases, guarantees and other automobile transaction services, as well as operates its own ride-hailing platform aimed principally at the growing online ride-hailing market in Senmiao's areas of operation in China. For more information about Senmiao, please visit: http://www.senmiaotech.com. Senmiao routinely provides important updates on its website. Cautionary Note Regarding Forward-Looking Statements This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These forward-looking statements (including those relating to the operation of Senmiao's ride-hailing platform) are subject to significant risks, uncertainties and assumptions, including those detailed from time to time in the Senmiao's filings with the SEC, and represent Senmiao's views only as of the date they are made and should not be relied upon as representing Senmiao's views as of any subsequent date. Senmiao undertakes no obligation to publicly revise any forward-looking statements to reflect changes in events or circumstances. For more information, please contact: At the Company: Yiye ZhouEmail: edom333@ihongsen.comPhone: +86 28 6155 4399 Investor Relations: The Equity Group Inc. Carolyne Sohn, Vice President +1 408-538-4577 csohn@equityny.com Alice Zhang, Associate+1 212-836-9610azhang@equityny.com In China Lucy Ma, Associate+86 10 5661 7012lma@equityny.com
A12 藝術空間
partnership
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
